Zheng et al. suggest that the HRAS transformed breast cancer cell line MCF10a, derived from an early stage cancer, exhibits a profound alteration in glucose metabolism and is strongly regulated by the oncogenic proteins HIF-1α and c-Myc [130]. The gene discussed is MYC; the disease is cancer.